---

$0.17

-0.0098 ( -5.51% ) 7.1M

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-01-04	Sale	-543750.00	Giraudo Bryan
2024-01-04	Sale	-1312500.00	Hasnain Faheem
2023-12-05	Sale	-1500000.00	Smith Robert Paul JR
2023-11-29	Sale	-230000.00	Quisel John D
2023-11-22	Sale	-162500.00	Aranda Richard
2023-11-22	Sale	-181250.00	Giraudo Bryan
2023-11-22	Sale	-125000.00	Peterson Caryn
2023-11-22	Sale	-437500.00	Hasnain Faheem
2023-11-22	Sale	-125000.00	Christian Waage
2023-11-17	Buy	32000.00	Milligan Sandra